Basic Information
RNALocate ID: | RLID:11002514 |
RNA Symbol: | hsa-miR-378a-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-378a-5p |
RNA ID: | miRBase:MIMAT0000731 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23077538 |
Tissue/Cell Line: | Plasma |
Method: | Solexa sequencing |
Description: | To characterize the stability of secreted miRNAs in plasma, we selected eight plasma miRNAs with relatively high copy numbers detected by Solexa sequencing (Table S1).Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002041 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11002511 | Exosome | Plasma | 29323722 |
RLID:11002512 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002513 | Exosome | Plasma | 23663360 |
RLID:11002515 | Microvesicle | Serum | 24797360 |
RLID-D:11000122 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Colon tissue|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue | |
RLID-D:11000419 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-378a-5p | Oral squamous cell carcinoma | MNDR-E-MI-46535 |
MNDR | hsa-miR-378a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-46536 |
MNDR | hsa-miR-378a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-46537 |
MNDR | hsa-miR-378a-5p | Lymphoma | MNDR-E-MI-46538 |
MNDR | hsa-miR-378a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-46539 |
MNDR | hsa-miR-378a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-46540 |
MNDR | hsa-miR-378a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-46541 |
MNDR | hsa-miR-378a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-46542 |
MNDR | hsa-miR-378a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-46543 |
MNDR | hsa-miR-378a-5p | Breast cancer luminal | MNDR-E-MI-46544 |
MNDR | hsa-miR-378a-5p | Dermatomyositis | MNDR-E-MI-46545 |
MNDR | hsa-miR-378a-5p | Prostate cancer | MNDR-E-MI-46546 |
MNDR | hsa-miR-378a-5p | Gastric cancer | MNDR-E-MI-46547 |
MNDR | hsa-miR-378a-5p | Alzheimer disease | MNDR-E-MI-46548 |
MNDR | hsa-miR-378a-5p | Intracranial aneurysm | MNDR-E-MI-46549 |
MNDR | hsa-miR-378a-5p | Bladder cancer | MNDR-E-MI-46550 |
MNDR | hsa-miR-378a-5p | Esophageal carcinoma | MNDR-E-MI-46551 |
MNDR | hsa-miR-378a-5p | Seizures | MNDR-E-MI-46552 |
MNDR | hsa-miR-378a-5p | Cardiovascular disease | MNDR-E-MI-46553 |
MNDR | hsa-miR-378a-5p | Lung cancer | MNDR-E-MI-46554 |
MNDR | hsa-miR-378a-5p | Parkinson disease | MNDR-E-MI-46555 |
MNDR | hsa-miR-378a-5p | Breast cancer | MNDR-E-MI-46556 |
MNDR | hsa-miR-378a-5p | Pituitary neoplasms | MNDR-E-MI-46557 |
MNDR | hsa-miR-378a-5p | Pancreatic cancer | MNDR-E-MI-46558 |
MNDR | hsa-miR-378a-5p | Melanoma | MNDR-E-MI-46559 |
MNDR | hsa-miR-378a-5p | Williams syndrome | MNDR-E-MI-46560 |
MNDR | hsa-miR-378a-5p | Rectum adenocarcinoma | MNDR-E-MI-46561 |
MNDR | hsa-miR-378a-5p | Nephroblastoma | MNDR-E-MI-46562 |
MNDR | hsa-miR-378a-5p | Colon cancer | MNDR-E-MI-46563 |
MNDR | hsa-miR-378a-5p | Colon adenocarcinoma | MNDR-E-MI-46564 |
MNDR | hsa-miR-378a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-46565 |
MNDR | hsa-miR-378a-5p | Familial ovarian cancer | MNDR-E-MI-46566 |
MNDR | hsa-miR-378a-5p | Acromegaly | MNDR-E-MI-46567 |
MNDR | hsa-miR-378a-5p | Prostate adenocarcinoma | MNDR-E-MI-46568 |
MNDR | hsa-miR-378a-5p | Kidney cancer | MNDR-E-MI-46569 |
MNDR | hsa-miR-378a-5p | Carcinoma ductal breast | MNDR-E-MI-46570 |
MNDR | hsa-miR-378a-5p | Glioblastoma | MNDR-E-MI-46571 |
MNDR | hsa-miR-378a-5p | Glioma | MNDR-E-MI-46572 |
MNDR | hsa-miR-378a-5p | Inclusion body myositis | MNDR-E-MI-46573 |
MNDR | hsa-miR-378a-5p | Breast carcinoma | MNDR-E-MI-46574 |
MNDR | hsa-miR-378a-5p | Infarction middle cerebral artery | MNDR-E-MI-46575 |
MNDR | hsa-miR-378a-5p | Gastric adenocarcinoma | MNDR-E-MI-46576 |
MNDR | hsa-miR-378a-5p | Pituitary adenoma | MNDR-E-MI-46577 |
MNDR | hsa-miR-378a-5p | Lung squamous cell carcinoma | MNDR-E-MI-46578 |
MNDR | hsa-miR-378a-5p | Lung adenocarcinoma | MNDR-E-MI-46579 |
MNDR | hsa-miR-378a-5p | Ovarian carcinoma | MNDR-E-MI-46580 |
MNDR | hsa-miR-378a-5p | Bladder urothelial carcinoma | MNDR-E-MI-46581 |
MNDR | hsa-miR-378a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-46582 |
MNDR | hsa-miR-378a-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-46583 |
MNDR | hsa-miR-378a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-46584 |
MNDR | hsa-miR-378a-5p | Renal clear cell carcinoma | MNDR-E-MI-46585 |
MNDR | hsa-miR-378a-5p | Cholangiocarcinoma | MNDR-E-MI-46586 |
MNDR | hsa-miR-378a-5p | Synovial sarcoma | MNDR-E-MI-46587 |
MNDR | hsa-miR-378a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-46588 |
MNDR | hsa-miR-378a-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-46589 |
MNDR | hsa-miR-378a-5p | Breast invasive carcinoma | MNDR-E-MI-46590 |
MNDR | hsa-miR-378a-5p | Hepatocellular carcinoma | MNDR-E-MI-46591 |
MNDR | hsa-miR-378a-5p | Familiar ovarian carcinoma | MNDR-E-MI-46592 |
MNDR | hsa-miR-378a-5p | Hodgkin lymphoma | MNDR-E-MI-46593 |
MNDR | hsa-miR-378a-5p | Neuromyelitis optica | MNDR-E-MI-46594 |
MNDR | hsa-miR-378a-5p | Skin cutaneous melanoma | MNDR-E-MI-46595 |
MNDR | hsa-miR-378a-5p | Skin melanoma | MNDR-E-MI-46596 |
MNDR | hsa-miR-378a-5p | Colorectal cancer | MNDR-E-MI-46597 |
MNDR | hsa-miR-378a-5p | St elevation myocardial infarction | MNDR-E-MI-46598 |
MNDR | hsa-miR-378a-5p | Cardiac hypertrophy | MNDR-E-MI-46599 |
MNDR | hsa-miR-378a-5p | Prostatic neoplasms | MNDR-E-MI-46600 |
MNDR | hsa-miR-378a-5p | Sarcopenia | MNDR-E-MI-46601 |
MNDR | hsa-miR-378a-5p | Stroke lacunar | MNDR-E-MI-46602 |
MNDR | hsa-miR-378a-5p | Breast cancer her3+ negative | MNDR-E-MI-46603 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | GABPA | Homo sapiens | RR00600117 |
TOP